NO980095L - Nye quinoxalin- og quinoxalinylalkan-forfonsyrer - Google Patents

Nye quinoxalin- og quinoxalinylalkan-forfonsyrer

Info

Publication number: NO980095L
Authority: NO; Norway
Prior art keywords: free; quinoxalinyl; esterified; alkane; aliphatic
Prior art date: 1995-07-10

Application number

NO980095A

Other languages

English (en)

Norwegian (no)

Other versions

NO980095D0 (no

Inventor

Robert Moretti

Hans Allgeier

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-10

Filing date

1998-01-09

Publication date

1998-03-05

1998-01-09 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1998-01-09 Publication of NO980095D0 publication Critical patent/NO980095D0/no

1998-03-05 Publication of NO980095L publication Critical patent/NO980095L/no

Links

XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 title abstract 4
-1 quinoxalinyl alkane Chemical class 0.000 title abstract 2
239000002253 acid Substances 0.000 title 1
150000007513 acids Chemical class 0.000 title 1
HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
125000003396 thiol group Chemical class [H]S* 0.000 abstract 2
IVHVNMLJNASKHW-UHFFFAOYSA-M Chlorphonium chloride Chemical compound [Cl-].CCCC[P+](CCCC)(CCCC)CC1=CC=C(Cl)C=C1Cl IVHVNMLJNASKHW-UHFFFAOYSA-M 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
125000001931 aliphatic group Chemical group 0.000 abstract 1
150000001412 amines Chemical class 0.000 abstract 1
125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
230000003042 antagnostic effect Effects 0.000 abstract 1
230000000903 blocking effect Effects 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
150000002431 hydrogen Chemical class 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
125000000449 nitro group Chemical class [O-][N+](*)=O 0.000 abstract 1
230000001575 pathological effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO980095A 1995-07-10 1998-01-09 Nye quinoxalin- og quinoxalinylalkan-forfonsyrer NO980095L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CH200995		1995-07-10
PCT/EP1996/002866 WO1997003079A1 (en)	1995-07-10	1996-07-01	Novel quinoxaline- and quinoxalinylalkane-phosphonic acids

Publications (2)

Publication Number	Publication Date
NO980095D0 NO980095D0 (no)	1998-01-09
NO980095L true NO980095L (no)	1998-03-05

Family

ID=4223780

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO980095A NO980095L (no)	1995-07-10	1998-01-09	Nye quinoxalin- og quinoxalinylalkan-forfonsyrer

Country Status (15)

Country	Link
EP (1)	EP0837864A1 (cs)
JP (1)	JPH11508902A (cs)
KR (1)	KR19990028839A (cs)
AU (1)	AU6516296A (cs)
BR (1)	BR9609644A (cs)
CA (1)	CA2224718A1 (cs)
CZ (1)	CZ5398A3 (cs)
HU (1)	HUP9901345A3 (cs)
IL (1)	IL122872A0 (cs)
NO (1)	NO980095L (cs)
PL (1)	PL324340A1 (cs)
SK (1)	SK2798A3 (cs)
TR (1)	TR199800022T1 (cs)
WO (1)	WO1997003079A1 (cs)
ZA (1)	ZA965800B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TR199900897T2 (xx) *	1996-10-24	1999-07-21	Novartis Ag	Ornat�lm�� aminoalkanfosfonik asitler.
US6841684B2 (en)	1997-12-04	2005-01-11	Allergan, Inc.	Imidiazoles having reduced side effects
US6329369B1 (en)	1997-12-04	2001-12-11	Allergan Sales, Inc.	Methods of treating pain and other conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5118675A (en) *	1991-02-15	1992-06-02	American Home Products Corporation	Quinoxaline phosphono-amino acids
IL109397A0 (en) *	1993-04-28	1994-07-31	Schering Ag	Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same

1996
- 1996-07-01 HU HU9901345A patent/HUP9901345A3/hu unknown
- 1996-07-01 TR TR1998/00022T patent/TR199800022T1/xx unknown
- 1996-07-01 SK SK27-98A patent/SK2798A3/sk unknown
- 1996-07-01 JP JP9505465A patent/JPH11508902A/ja active Pending
- 1996-07-01 WO PCT/EP1996/002866 patent/WO1997003079A1/en not_active Ceased
- 1996-07-01 AU AU65162/96A patent/AU6516296A/en not_active Abandoned
- 1996-07-01 PL PL96324340A patent/PL324340A1/xx unknown
- 1996-07-01 EP EP96924829A patent/EP0837864A1/en not_active Withdrawn
- 1996-07-01 BR BR9609644A patent/BR9609644A/pt not_active Application Discontinuation
- 1996-07-01 IL IL12287296A patent/IL122872A0/xx unknown
- 1996-07-01 CZ CZ9853A patent/CZ5398A3/cs unknown
- 1996-07-01 CA CA002224718A patent/CA2224718A1/en not_active Abandoned
- 1996-07-01 KR KR1019980700140A patent/KR19990028839A/ko not_active Withdrawn
- 1996-07-09 ZA ZA965800A patent/ZA965800B/xx unknown
1998
- 1998-01-09 NO NO980095A patent/NO980095L/no unknown

Also Published As

Publication number	Publication date
JPH11508902A (ja)	1999-08-03
ZA965800B (en)	1997-01-10
AU6516296A (en)	1997-02-10
PL324340A1 (en)	1998-05-25
BR9609644A (pt)	1999-05-11
MX9800332A (es)	1998-07-31
SK2798A3 (en)	1998-07-08
HUP9901345A3 (en)	2000-01-28
TR199800022T1 (xx)	1998-05-21
CA2224718A1 (en)	1997-01-30
HUP9901345A2 (hu)	1999-08-30
NO980095D0 (no)	1998-01-09
WO1997003079A1 (en)	1997-01-30
EP0837864A1 (en)	1998-04-29
CZ5398A3 (cs)	1998-06-17
KR19990028839A (ko)	1999-04-15
IL122872A0 (en)	1998-08-16

Similar Documents

Publication	Publication Date	Title
ID21927A (id)	1999-08-12	Asam aminoalkanafosfonat tersubstitusi
MY103021A (en)	1993-04-30	Fluoroalkoxy substituted benzimidazoles useful as gastric acid secretion inhibitors
ATE233256T1 (de)	2003-03-15	2-pyrimidinamin derivaten und verfahrens zu deren herstellung
KR870000289A (ko)	1987-02-17	트리시클로데칸의 (메트)-아크릴산 유도체의 제조방법
DK0863875T3 (da)	2003-12-01	Hidtil ukendte 4-(oxyalkoxyphenyl)-3-oxy-piperiner til behandling af hjerte- og nyrelidelser
ATE187445T1 (de)	1999-12-15	Verfahren zur herstellung von chinazolinderivaten
ATE284853T1 (de)	2005-01-15	Ureido-thiobuttersäurederivate als ppar-agonisten
ATE106863T1 (de)	1994-06-15	Derivate von n-phenylbenzamid mit antiulcerativer sowie antiallergischer aktivität und verfahren zu ihrer herstellung.
ES546935A0 (es)	1986-03-16	Procedimiento para la preparacion de derivados anilinicos para la deteccion de sistemas redox
NO955326L (no)	1996-07-01	Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
BR0005005A (pt)	2001-01-02	Aditivo de polìmero para um meio de banho alcalino de eletrogalvanização de zinco ou liga de zinco, meio de banho alcalino de zinco ou liga de zinco, processo para eletrogalvanizar zinco e/ou ligas de zinco em um substrato condutivo, e uso do polìmero
DE59808284D1 (de)	2003-06-12	Cycloalkylalkancarbonsäureamide, deren herstellung und verwendung
ATE60061T1 (de)	1991-02-15	Ankondensierte siebengliedrige ringverbindungen, ihre herstellung und ihre verwendung.
NO980095L (no)	1998-03-05	Nye quinoxalin- og quinoxalinylalkan-forfonsyrer
DE69008542D1 (de)	1994-06-01	Chinolinderivate, ihre herstellung und verwendung.
ES8604922A1 (es)	1986-02-16	Procedimiento para la preparacion de n-piridilindoles
NO971142L (no)	1997-03-12	Bis-(2-halogenetyl)aminofenylsubstituerte distamycinderivater som antitumor- og antivirale midler
ES8800122A1 (es)	1987-10-16	Un procedimiento para la preparacion de derivados de indeno y naftaleno.
DK227085D0 (da)	1985-05-22	1-halogen-1-azolyl-2,2-diaryl-ethan-derivater, salte og metalkomplekser deraf samt deres fremstilling og anvendelse
ES8403456A1 (es)	1984-03-16	"procedimiento para la obtencion de una composicion a base de 1,4-dihidropiridina de accion anti-arteriosclerotica".
KR930702269A (ko)	1993-09-08	포스포리파제 a2저해 물질
DK0668852T3 (da)	1998-03-16	Substituerede orthoethenylphenyleddikesyrederivater
NO951588L (no)	1995-06-27	4-kinolinylderivater
TR199903159T2 (xx)	2000-07-21	Yeni �-Amino ve �-Azido karbonik asit t�revleri.
ES2059513T3 (es)	1994-11-16	Un procedimiento para la preparacion de un derivado cinamoilamida.